Fetal Alcohol Spectrum Disorders Clinical Trial
Official title:
Early Identification of Affected Children and Nutritional Risk Factors for FASD in Ukraine
Interventional study randomizing pregnant women at two sites in Ukraine who have or have not already consumed moderate to heavy levels of alcohol in pregnancy to receiving a standard prenatal vitamin supplement with or without additional choline supplement or standard of care (recommendation to take vitamin supplements) through the remainder of pregnancy, and to compare neurobehavioral performance of the offspring on the Bayley Scales of Infant Development at 12 months of age between groups. The overall sample size target was 300 alcohol exposed and 300 low or unexposed across both sites.
Pregnant women coming in for routine prenatal diagnostic testing or prenatal care at two
sites in Ukraine, Rivne Diagnostic Center or Khmelnytsky Regional Perinatal Center, were
screened for alcohol consumption during pregnancy. Those who met the criteria of consuming
4-5 drinks per occasion on 3-4 occasions in either the month around conception or the most
recent month of pregnancy were eligible for recruitment into the alcohol exposed group, and
the next available woman who consumed no more than 2 drinks on any occasion in the month
around conception or the most recent month of pregnancy was eligible for recruitment into the
alcohol low or no exposure group. Within alcohol group and within site, women were randomized
on a 1:1 basis to receiving a study-provided prenatal vitamin (TheraVit) manufactured in the
U.S. and registered in Ukraine as an over-the-counter product, or to receiving standard of
care which is obstetric advice to take prenatal vitamins on their own. Within the group
randomized to receiving the prenatal vitamins, women were further randomized on a 1:1 basis
to receiving an additional 750 mg. of supplemental choline manufactured in the U.S., and
registered in Ukraine as an over-the-counter product.
Women in both cohorts were followed until delivery and those with live born children were
followed until the child reached one year of age. The primary endpoint for the intervention
was performance on the mental developmental index (MDI) and the psychomotor developmental
index (PDI) components of the Bayley Scales of Infant Development II. The Bayley tests were
administered at approximately 12 months adjusted chronological age by trained psychologists
in Ukraine.
The primary comparison for the study was within the alcohol-exposed group, comparing mean
Bayley scores on MDI and separately on PDI between those randomized to receiving the study
prenatal vitamin and those randomized to standard of care.
Secondary comparisons for the study examined
1. the mean MDI and PDI scores on the Bayley within the alcohol-exposed group in those
randomized to receiving the prenatal vitamin plus choline vs. those who received the
prenatal vitamin alone
2. the mean MDI and PDI scores on the Bayley within the low or unexposed group in those who
received the prenatal vitamin vs. those who did not
3. the mean MDI and PDI scores on the Bayley within the low or unexposed group in those who
received the prenatal vitamin plus choline vs. those who received the prenatal vitamin
alone
4. adjusted comparisons for all of the above taking into account participants who were
taking vitamins on their own at the time of enrollment, and/or who were taking vitamins
on their own if assigned to the standard of care group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Completed |
NCT01961050 -
Preventing FAS/ARND in Russian Children
|
N/A | |
Recruiting |
NCT05108974 -
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
|
Phase 2 | |
Completed |
NCT02457676 -
Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention
|
N/A | |
Recruiting |
NCT06005181 -
The Synchrony Study: Examining Music Training for Children With FASD
|
N/A | |
Completed |
NCT04571463 -
Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
|
||
Completed |
NCT03361293 -
Cognitive Training and tDCS for Children With FASD
|
N/A | |
Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
Recruiting |
NCT05456321 -
CIFASD 5 tDCS and Cognitive Training
|
N/A | |
Completed |
NCT01911299 -
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
Recruiting |
NCT04332172 -
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
|
N/A | |
Recruiting |
NCT05960461 -
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
|
N/A | |
Completed |
NCT05604014 -
Feasibility Study of the My Health Coach App for Adults With FASD
|
N/A | |
Terminated |
NCT03852550 -
READYorNot[TM] Brain-Based Disabilities Trial
|
N/A | |
Completed |
NCT02735473 -
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
Not yet recruiting |
NCT04918043 -
Alcohol Use During Pregnancy in Finland According to Meconium Samples
|
||
Completed |
NCT04072809 -
Dissecting the Genetics of Fetal Alcohol Spectrum Disorders
|
||
Completed |
NCT01149538 -
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
|
Phase 1/Phase 2 | |
Completed |
NCT05028517 -
Efficacy Trial of the FMF Connect Mobile Health Intervention
|
N/A | |
Completed |
NCT04194489 -
Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention
|
N/A |